| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |